Skip to main content

Table 1 Study population (before matching)

From: Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink

  Emollient
(n = 45,218)
Non-Emollient
(n = 9780)
Regional distribution %
 East Midlands 8.91 10.55
 London 12.5 8.67
 North East 1.75 3.13
 North West 11.87 14.66
 Northern Ireland 3.7 1.51
 Scotland 10.79 9.62
 South Central 11.62 13.15
 South East Coast 7.95 11.13
 South West 7.2 8.26
 Wales 12.36 6.56
 West Midlands 9.43 10.47
 Yorkshire and Humber 1.92 2.27
Age distribution %
 Less than 1 year 13.43 1.17
 1 to 5 years 29.24 6.13
 6 to 10 years 7.1 3.21
 11 to 15 years 5.64 3.64
 16 to 18 years 2.87 2.32
 19 to 65 years 26.38 63.11
 More than 65 years 15.33 20.42
Disease type %
 Atopic dermatitis/eczema 43.62 26.24
 Contact dermatitis 2.8 6.95
 Dermatitis NOS 6.31 14.39
 Dermatitis/dermatoses 1.49 2.84
 Eczema NOS 18.36 15.12
 Flexural eczema 3.37 1.44
 Hand eczema 1.04 1.29
 Infantile eczema 13.84 1.55
 Infected eczema 2.57 4.54
 Itch 2.06 7.46
 Pruritus NOS 3.28 9.71
 Seborrhoeic dermatitis capitis 0.45 5.62
 Skin irritation 0.81 2.85
  1. Note that responses from 1451 subjects for Disease Type were missing and not included in this analysis
  2. NOS, not otherwise specified